Stockholders’ Deficit and Stock-Based Compensation - Schedule of Options Activity (Details) - 2022 Omnibus Plan - Options to purchase common stock - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2024	Dec. 31, 2023
Shares
Balances at the beginning (in shares)	371,116
Granted (in shares)	0
Exercised (in shares)	(8,338)
Forfeited(in shares)	(1,416)
Balances at the ending (in shares)	361,362	371,116
Weighted Average Exercise Price
Balances at the beginning (in dollars per share)	$ 2.51
Granted (in dollars per share)	0
Exercised (in dollars per share)	2.62
Forfeited (in dollars per share)	2.69
Balances at the ending (in dollars per share)	$ 2.51	$ 2.51
Weighted Average Contractual Life (in years)
Balances at the ending (in years)	8 years 6 months 10 days	8 years 9 months 7 days
Aggregate Intrinsic Value (in thousands)
Outstanding at beginning of period	$ 4,591
Granted	0
Exercised	172
Forfeited	15
Outstanding at end of period	$ 4,596	$ 4,591
Vested and exercisable at period end (in shares)	103,072
Vested and exercisable at period end (in dollars per share)	$ 2.55
Vested and exercisable at period end (in years)	8 years 5 months 23 days
Vested and exercisable at end of period (intrinsic value)	$ 1,308